Should the 14-day rule for embryo research become the 28-day rule?

John B. Appleby, Annelien L. Bredenoord

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The “14-day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14-day-old embryo (Hyun et al,; Nuffield Council on Bioethics,). For several decades, the 14-day rule has been a shining example of how science policy and regulation can be developed with interdisciplinary consensus and applied across a number of countries to help fulfil an ethical and practical purpose: to facilitate efficient and ethical embryo research. However, advances in embryology and biomedical research have led to suggestions that the 14-day rule is no longer adequate (Deglincerti et al,; Shahbazi et al,; Hurlbut et al,). Therefore, should the 14-day rule be extended and, if so, where should we draw a new line for permissible embryo research? Here, we provide scientific, regulatory and ethical arguments that the 14-day rule should be extended to 28 days (or the developmental equivalent stage of a 28-day-old embryo).

Original languageEnglish
Article numbere9437
JournalEmbo Molecular Medicine
Volume10
Issue number9
DOIs
Publication statusPublished - 1 Sept 2018

Fingerprint

Dive into the research topics of 'Should the 14-day rule for embryo research become the 28-day rule?'. Together they form a unique fingerprint.

Cite this